CARLIER, Jeremy

CARLIER, Jeremy  

Dipartimento Scienze Biomediche e Sanita' Pubblica  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.04 secondi).
Titolo Data di pubblicazione Autore(i) File
A 2017-2019 Update on Acute Intoxications and Fatalities from Illicit Fentanyl and Analogs 1-gen-2021 Brunetti, P.; Pirani, F.; Carlier, J.; Giorgetti, R.; Busardo, F. P.; Lo Faro, A. F.
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry 1-gen-2017 Wohlfarth, A.; Roman, M.; Andersson, M.; Kugelberg, F. C.; Diao, X.; Carlier, J.; Eriksson, C.; Wu, X.; Konradsson, P.; Josefsson, M.; Huestis, M. A.; Kronstrand, R.
3F-α-pyrrolydinovalerophenone (3F-α-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining 1-gen-2022 Carlier, J.; Berardinelli, D.; Montanari, E.; Sirignano, A.; Di Trana, A.; Busardo, F. P.
Acute Intoxications and Fatalities Associated with Benzimidazole Opioid (Nitazene Analog) Use: A Systematic Review 1-gen-2022 Montanari, E.; Madeo, G.; Pichini, S.; Busardo, F. P.; Carlier, J.
Advances in forensic toxicology 1-gen-2020 Malaca, S.; Carlier, J.; Busardo, F. P.
Atropine eye drops: An unusual homicidal poisoning 1-gen-2014 Carlier, J.; Escard, E.; Peoc'H, M.; Boyer, B.; Romeuf, L.; Faict, T.; Guitton, J.; Gaillard, Y.
Cannabidiol adverse effects and toxicity 1-gen-2019 Huestis, M. A.; Solimini, R.; Pichini, S.; Pacifici, R.; Carlier, J.; Busardo, F. P.
Consequences of COVID-19 Lockdown on the Misuse and Marketing of Addictive Substances and New Psychoactive Substances 1-gen-2020 Di Trana, A.; Carlier, J.; Berretta, P.; Zaami, S.; Ricci, G.
Distinguishing intake of new synthetic cannabinoids ADB-PINACA and 5F-ADB-PINACA with human hepatocyte metabolites and high-resolution mass spectrometry 1-gen-2017 Carlier, J.; Diao, X.; Scheidweiler, K. B.; Huestis, M. A.
Drug-facilitated sexual assaults (DFSA): A serious underestimated issue 1-gen-2019 Busardo, F. P.; Vari, M. R.; Trana, A. D. I.; Malaca, S.; Carlier, J.; Di Luca, N. M.
Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material 1-gen-2013 Mazoyer, C.; Carlier, J.; Boucher, A.; Peoc'H, M.; Lemeur, C.; Gaillard, Y.
Fatal intoxication after taking iboga: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and post-mortem material 1-gen-2012 Mazoyer, C.; Carlier, J.; Peoc'H, M.; Lemeur, C.; Boucher, A.; Bevalot, F.; Guitton, J.; Gaillard, Y.
Fatal intoxication due to ackee (Blighia sapida) in Suriname and French Guyana. GC-MS detection and quantification of hypoglycin-A 1-gen-2011 Gaillard, Y.; Carlier, J.; Berscht, M.; Mazoyer, C.; Bevalot, F.; Guitton, J.; Fanton, L.
Human Hepatocyte 4-Acetoxy-N,N-Diisopropyltryptamine Metabolite Profiling by Reversed-Phase Liquid Chromatography Coupled with High-Resolution Tandem Mass Spectrometry 1-gen-2022 Malaca, Sara; Huestis, Marilyn A.; Lattanzio, Leonardo; Marsella, Luigi T.; Tagliabracci, Adriano; Carlier, Jeremy; Busardò, Francesco P.
Human hepatocyte metabolism of novel synthetic cannabinoids MN-18 and its 5-fluoro analog 5F-MN-18 1-gen-2017 Diao, X.; Carlier, J.; Zhu, M.; Huestis, M. A.
Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes 1-gen-2017 Carlier, J.; Diao, X.; Sempio, C.; Huestis, M. A.
In silico prediction, LC-HRMS/MS analysis, and targeted/untargeted data-mining workflow for the profiling of phenylfentanyl in vitro metabolites 1-gen-2021 Di Trana, A.; Brunetti, P.; Giorgetti, R.; Marinelli, E.; Zaami, S.; Busardo, F. P.; Carlier, J.
In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping 1-gen-2022 Busardo, F. P.; Lo Faro, A. F.; Sirignano, A.; Giorgetti, R.; Carlier, J.
In silico, in vitro, and in vivo human metabolism of acetazolamide, a carbonic anhydrase inhibitor and common “diuretic and masking agent” in doping 1-gen-2022 Busardo, F. P.; Lo Faro, A. F.; Sirignano, A.; Giorgetti, R.; Carlier, J.
In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201) 1-gen-2017 Diao, X.; Carlier, J.; Zhu, M.; Pang, S.; Kronstrand, R.; Scheidweiler, K. B.; Huestis, M. A.